Dropless Cataract Surgery

Dropless-Cataract-Surgery

With dropless cataract surgery, a single-use antibiotic and steroid injection are administered at the end of cataract surgery while the patient is still under anesthesia. During the following month, the eye absorbs this combination, so patients don’t have to worry about administering eye drops postoperatively. 

Traditionally, ophthalmologists prescribed two or three eye drop medications that needed to be instilled into the operated eye three or four times a day for 4 to 6 weeks. Proper use of these medications is critical for preventing postoperative vision-threatening complications such as Endophthalmitis and Cystoid Macular Edema. In addition to some of these prescription medications costing patients hundreds of out-of-pocket dollars, patients often forgot to put them in and many had physical difficulties with handling the bottles and assuring the proper amount of medication got into the eye. Over the past few years, a number of studies have shown that placing antibiotics and steroid medications inside the eye at the end of cataract surgery is more effective at preventing these vision-threatening complications and eliminating patient compliance issues with drops. Doctors have been doing dropless cataract surgery for years in Europe with great success and it is starting to become more popular in the U.S. Over 500,000 cases have been done with Tri-Moxi nationwide. 

Dr. Swale and Dr. Franklin, at Fisher-Swale-Nicholson Eye Center, are amongst the few eye doctors in Illinois who use this technique. 

Benefits for Dropless Cataract Surgery

Here are just some of the few demonstrated benefits for dropless cataract surgery:

More Convenient 

Dropless cataract surgery reduces or eliminates the need for eye drops after cataract surgery. This translates to not having to put drops in your eyes four times a day and freeing up more time.

This is extremely helpful for cataract patients who tend to be older and more prone to physical and cognitive challenges that may make opening bottles, instilling drops and remembering dosing regimens a struggle. 

More Reliable Drug Delivery

Patients are assured that their eyes are getting the medications needed to protect from infection and macular edema.

Less Expensive

No more drops pre or post-op! The surgery center or hospital will cover the cost of the injection, and the financial burden and confusion associated with eye drops will be eliminated.

Patients do not have to pay out of pocket for dropless like they would for prescription drops. The dropless injection portion of the surgery is included in our surgery center fees. This translates into a potential savings of $400 for both eyes on prescription eye drops.

The traditional post-op regimen of topical antibiotic, steroid and NSAID can pose a significant cost burden to patients, even those with health insurance. Having dropless cataract surgery eliminates the need for patients to purchase both a topical steroid and antibiotic. 

Safe and Effective

With dropless cataract surgery, there is a low risk of infection, retinal swelling, and other complications. Over the past few years, a number of studies have also demonstrated how placing antibiotics and steroid medications inside the eye at the end of cataract surgery is more effective at preventing these vision-threatening complications and eliminating patient compliance issues with drops. Dropless simplifies the post-operative process for patients, making it less of a hassle to get back to seeing well and enjoying life.

Dropless Cataract Surgery FAQs

The single-use vial contains a formulation of Tri-Moxi (triamcinolone 15 mg/mL plus 1mg/mL moxifloxacin) manufactured by Imprimis Pharmaceuticals.

Since the injection is administered while the patient is still under anesthesia, the injection is usually painless and only causes temporary postoperative floaters.

ImprimisRx compounded formulations are not FDA-approved. All formulations are compounded with active pharmaceutical ingredients (APIs) from FDA-registered manufacturers.

Currently, no billing code exists for post-surgical injections, and since Dropless® formulations have been identified as part of the procedure, they do not allow for reimbursement and do not allow for a patient to be charged separately.

Dropless cataract surgery has improved patient compliance, reducing pharmacologic cost and increasing the post-op drop convenience–and these all positively affect patient satisfaction. In one study, patients show a statistically significant preference for injectable medications at the conclusion of cataract surgery over postoperative drops

Contact Us

Fisher-Swale-Nicholson Eye Center is excited to bring Tri-Moxi to our cataract patients. If you have questions about Dropless Cataract Surgery or think you may have a cataract, please call us at (815) 932-2020 to schedule an appointment today or you may request an appointment online.